Dr. Schenk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 720-848-0000
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2014 - 2018
Clinician Investigator Training Program-, Tumor Immunology, 2014 - 2016- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2011 - 2014
- Mayo Clinic College of MedicineClass of 2011
Certifications & Licensure
CO State Medical License 2018 - 2025
MN State Medical License 2012 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Mayo Graduate SchoolPhD
Publications & Presentations
PubMed
- Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in No...Alexander S Watson, Harris B Krause, Andrew Elliott, Alex Farrell, Stephen V Liu
Clinical Lung Cancer. 2024-12-01 - The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitiz...Tejas Patil, Dexiang Gao, Alexander Watson, Mandy Sakamoto, Yunan Nie
Lung Cancer. 2024-11-25 - 7 citationsNeoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.Collin M Blakely, Anatoly Urisman, Matthew A Gubens, Claire K Mulvey, Greg M Allen
Journal of Clinical Oncology. 2024-09-10
Press Mentions
How the Immune System Affects Drug Response in Lung Cancer PatientsMay 10th, 2024
Translational Research Scholar Grant Supports Further Study of Immune Cell Changes During Lung Cancer TreatmentNovember 7th, 2022
ALK Positive Summit Focuses on Community and SurvivorshipAugust 1st, 2022- Join now to see all
Committees
- Member, ASCO Expert Panel Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations 2022 - Present
- Member, ASCO Expert Panel Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations 2022 - Present
Professional Memberships
- Member
- Member
- International Association for the Study of Lung CancerMember
External Links
- University of Colorado School of Medicinehttps://som.cuanschutz.edu/Profiles/Faculty/Profile/27915
- UCHelathhttps://www.uchealth.org/provider/erin-schenk-md-phd/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
